The ban by the Federal Government on codeine-containing cough syrups has affected the country’s pharmaceutical industry, especially companies that produce codeine or Benylin cough syrups say May & Baker Plc.
The pharmaceutical industry said that the ban caused it to lose N700 million in annua
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
